EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Loss of ATP-Dependent Citrate Lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling

Shijie Liu, Seth T Gammon iD, Lin Tan, Yaqi Gao iD, Kyoungmin Kim iD, Mahmoud H Elbatreek iD, Adrian Arrieta iD, Ian K Williamson, Rebecca L Salazar, Janet Pham iD, Angela Davidian, Radhika Khanna Neicheril und 23 weitere

Circulation · 21.07.2026 · 154 (3) · 223-239

DOI: 10.1161/circulationaha.125.076453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 21.07.2026. Verfasst von Shijie Liu und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Texas Heart Institute, Houston, TX (S.L., J.F.M.). Hauptthemen laut MEDLINE: ATP Citrate (pro-S)-Lyase, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Metabolic adaptation and maladaptation are hallmarks of the failing heart and may be a target for therapeutic interventions. For example, sustained glucose oxidation during cardiac stress is associated with increased activity and abundance of ACL (ATP-dependent citrate lyase, Acly ), which produces acetyl–coenzyme A (CoA) from citrate and CoA and supports de novo lipid synthesis. However, our understanding of how ACL supports cardiac metabolic adaptation and its potential to modulate disease pathophysiology has not yet been investigated. METHODS: We used human heart tissue samples from healthy donors and patients with nonischemic cardiomyopathy. Next, we used CRISPR (clustered, regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated 9) gene editing to inactivate Acly in cardiomyocytes of Myh6-Cas9 mice. In vivo positron emission tomography and ex vivo stable isotope tracer labeling were used to quantify metabolic flux changes in response to Acly knockdown. We conducted a multi-omics analysis using RNA sequencing and mass spectrometry–based metabolomics and proteomics. Experimental data were integrated into computational modeling using the metabolic network CardioNet to identify significantly dysregulated metabolic processes at a systems level. RESULTS: We observed reduced ACL abundance and activity in human heart tissue samples from patients with nonischemic cardiomyopathy, which correlated with decreased abundance of Krebs cycle intermediates. Using CRISPR/Cas9 gene editing, we found that cardiac-specific loss of ACL reduces acetyl-CoA synthesis, leading to altered cardiac metabolism characterized by increased glucose uptake and oxidation, impaired energy flux, and elevated AMP to ATP ratios, which collectively promote left ventricular dysfunction. Transcriptomic and mass spectrometry–based metabolomics, as well as proteomic data, reveal compensatory cardiac lipid remodeling and reduced histone 3 acetylation. This metabolic stress promotes activation of AMPK (AMP kinase) and PKA (protein kinase A), which in turn mediates YAP (Yes-associated protein) inhibition through phosphorylation. Stable isotope tracer studies combined with CardioNet simulations demonstrated that increased IDH1 (isocitrate dehydrogenase 1) activity prevents allosteric inhibition of glycolysis from cytosolic citrate accumulation. AAV9-mediated cardiac Idh1 deletion improved cardiac function and energy provision, reducing YAP phosphorylation and restoring downstream YAP signaling. CONCLUSIONS: Our findings suggest that ACL plays a pivotal role in cardiac metabolism through regulating lipid synthesis and cardiac function. Exploiting compensatory pathways of citrate metabolism may improve cardiac function during heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP Citrate (pro-S)-LyaseVentricular Dysfunction, LeftHumansAnimalsMiceMyocytes, CardiacMaleFemaleCardiomyopathiesEnergy Metabolism

Stichwörter der Autor:innen

ATP-dependent citrate lyasecardio-oncologymetabolismsystems biology

Substanzen

ATP Citrate (pro-S)-Lyase

Autor:innen und Institutionen

  • Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Texas Heart Institute, Houston, TX (S.L., J.F.M.).
  • Department of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, OH (S.L.).
  • Department of Cancer Systems Imaging (S.T.G., D.P.-W.), University of Texas MD Anderson Cancer Center, Houston.
  • Department of Bioinformatics and Computational Biology (L.T., S.A.M., P.L.L.), University of Texas MD Anderson Cancer Center, Houston.
  • Department of Cardiology (Y.G., K.K., I.K.W., R.L.S., J.P., A.D., A.S., L.S.C.C., E.P.K., A.K.), Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
  • Department of Cardiothoracic Surgery (M.H.E., L.S.C.C., D.J.L.), Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

ORCID-Profile: Seth T Gammon, Yaqi Gao, Kyoungmin Kim, Mahmoud H Elbatreek, Adrian Arrieta, Janet Pham, Benjamin D Gould, Heidi Vitrac, An Q Dinh, Evan C Lien, Francisca N de Luna Vitorino, Sara A Martinez, Melanie T Odenkirk, Anna K Boatman, Lawrence S C Czer, Evan P Kransdorf, David J Lefer, Blake M Hanson, Benjamin A Garcia, Erin M Baker, Matthew G Vander Heiden, Philip L Lorenzi, Heinrich Taegtmeyer, David Piwnica-Worms, James F Martin, Anja Karlstaedt

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • NICHD NIH HHS
  • NIH HHS
  • NIEHS NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Liu, S., Gammon, S. T., Tan, L., Gao, Y., Kim, K., Elbatreek, M. H., Arrieta, A., Williamson, I. K., Salazar, R. L., Pham, J., Davidian, A., Khanna Neicheril, R., Gould, B. D., Vitrac, H., Sadiq, A., Dinh, A. Q., Lien, E. C., de Luna Vitorino, F. N., Gongora, J. M., …, & Karlstaedt, A. (2026). Loss of ATP-Dependent Citrate Lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling. Circulation, 154(3), 223-239. https://doi.org/10.1161/circulationaha.125.076453

Vancouver

Liu S, Gammon ST, Tan L, Gao Y, Kim K, Elbatreek MH, et al. Loss of ATP-Dependent Citrate Lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling. Circulation. 2026;154(3):223-239. doi:10.1161/circulationaha.125.076453

BibTeX
@article{Liu2026,
  author = {Liu, Shijie and Gammon, Seth T and Tan, Lin and Gao, Yaqi and Kim, Kyoungmin and Elbatreek, Mahmoud H and Arrieta, Adrian and Williamson, Ian K and Salazar, Rebecca L and Pham, Janet and Davidian, Angela and Khanna Neicheril, Radhika and Gould, Benjamin D and Vitrac, Heidi and Sadiq, Alia and Dinh, An Q and Lien, Evan C and de Luna Vitorino, Francisca N and Gongora, Joanna M and Martinez, Sara A and Odenkirk, Melanie T and Boatman, Anna K and Chappel, Jessie R and Czer, Lawrence S C and Kransdorf, Evan P and Lefer, David J and Hanson, Blake M and Garcia, Benjamin A and Baker, Erin M and Vander Heiden, Matthew G and Lorenzi, Philip L and Taegtmeyer, Heinrich and Piwnica-Worms, David and Martin, James F and Karlstaedt, Anja},
  title = {Loss of ATP-Dependent Citrate Lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {3},
  pages = {223--239},
  doi = {10.1161/circulationaha.125.076453}
}
Kostenlos starten →